<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AIndividual_capital_guidance_%28ICG%29</id>
	<title>Definition:Individual capital guidance (ICG) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AIndividual_capital_guidance_%28ICG%29"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Individual_capital_guidance_(ICG)&amp;action=history"/>
	<updated>2026-06-13T22:19:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Individual_capital_guidance_(ICG)&amp;diff=11155&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Individual_capital_guidance_(ICG)&amp;diff=11155&amp;oldid=prev"/>
		<updated>2026-03-11T17:26:49Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏛️ &amp;#039;&amp;#039;&amp;#039;Individual capital guidance (ICG)&amp;#039;&amp;#039;&amp;#039; is a confidential, firm-specific capital requirement communicated by the UK&amp;#039;s [[Definition:Prudential Regulation Authority (PRA) | Prudential Regulation Authority]] (formerly the FSA) to an individual [[Definition:Insurance carrier | insurer]] or banking institution, setting out the minimum amount and quality of capital the regulator expects the firm to hold above the standard regulatory minimum. For insurance firms operating under the pre-[[Definition:Solvency II | Solvency II]] UK regime — and for banking entities under Basel frameworks — ICG represented the supervisor&amp;#039;s quantitative judgment on risks not fully captured by standardized capital rules, effectively tailoring capital requirements to the specific risk profile of each firm.&lt;br /&gt;
&lt;br /&gt;
⚙️ The PRA arrived at an insurer&amp;#039;s ICG through a supervisory review process that evaluated the firm&amp;#039;s own [[Definition:Internal capital model | internal capital assessment]] (known as the Individual Capital Adequacy Standards, or ICAS, process for insurers), stress testing results, risk management quality, and exposure concentrations. The regulator would then either endorse the firm&amp;#039;s self-assessed capital need or impose a higher figure, communicated privately as a percentage of the relevant regulatory capital requirement or as an absolute amount. Because ICG was confidential, it did not appear in public filings, and firms were prohibited from disclosing it — a feature designed to prevent market participants from drawing adverse inferences about individual companies.&lt;br /&gt;
&lt;br /&gt;
📌 Although [[Definition:Solvency II | Solvency II]] replaced much of the ICG framework for EU and UK insurers by introducing the [[Definition:Solvency capital requirement (SCR) | Solvency Capital Requirement]] and [[Definition:Minimum capital requirement (MCR) | Minimum Capital Requirement]] as public, risk-based standards, the concept of individualized supervisory capital add-ons did not disappear entirely. The PRA retains the ability to impose capital scalars and buffers on specific firms through its Pillar 2 supervisory process when it identifies risks — such as operational weaknesses, model deficiencies, or emerging exposures — that the standard framework does not adequately address. Understanding ICG and its legacy is important for insurance professionals involved in [[Definition:Capital management | capital management]], [[Definition:Regulatory compliance | regulatory engagement]], and [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] due diligence, since historical ICG levels can influence how legacy capital positions and regulatory relationships are assessed during transactions.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Minimum capital requirement (MCR)]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Prudential Regulation Authority (PRA)]]&lt;br /&gt;
* [[Definition:Internal capital model]]&lt;br /&gt;
* [[Definition:Capital management]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>